Back to Top Skip to main content

Navy unit provided COVID-19 support to Peruvian First Responders

Fireman getting COVID test in firehouse garage Bombero physician collects sample for testing at the Bellavista Fire Station No. 60 in Callao, Peru. (Courtesy Photo.)

Recommended Content:

Coronavirus | Global Health Engagement

U.S. Naval Medical Research Unit Number 6 (NAMRU-6) recently provided COVID-19 support to the Bellavista Fire Station No. 60 in Callao, Peru.

Responding to a reported COVID-19 exposure among the Bellavista Fire Station No. 60 firefighters, NAMRU-6 tested 45 de-identified, coded samples from firefighters with a possible exposure to individuals with confirmed cases SARS-CoV-2, the virus responsible for COVID-19 infection.

The testing performed by NAMRU-6 is based upon the detection of the virus’ nucleic acids through a sensitive method known as Real Time Reverse Transcriptase- Polymerase Chain Reaction. Results identified samples that showed detectable levels of the virus and were provided to fire station leadership the same day. Collaborating with the fire station medical and safety staff allowed immediate isolation of infected individuals to prevent further COVID-19 spread among emergency workers. 

The province of Callao has the second highest number of COVID-19 cases in Peru, and the implementation of infection control measures remains a critical component to slowing the spread of the virus. Through the foresight of the Bellavista Fire Station leadership and the swift response of NAMRU-6 scientists, Bellavista Fire Station No. 60 could continue their critical mission, which includes providing first responder support to the U.S. Navy lab.

The Bellavista Fire Station No. 60 is located on the Centro Médico Naval installation in Callao, which is where the NAMRU-6 compound is also located. The fire station has been supporting the lab dating back to 2009 when NAMRU-6 leadership identified gaps in emergency management response and annual exercises. NAMRU-6 requested firefighting and rescue response support from the fire station and the relationship became official in the NAMRU-6 Emergency Management Plan. The partnership currently supports annual exercises in emergency scenarios such as fire in a laboratory, large-scale chemical spills, large-scale biological spills, rescue of injured personnel, and health emergencies such as a heart attack. 

“The ability to provide a critical service to our Peruvian partners underscores the collaborative effort that NAMRU-6 seeks with all our partners, especially during this unprecedented global crisis,” said U.S. Navy Cmdr. Michael Prouty, deputy research science director at NAMRU-6.

NAMRU-6 Safety Director Roberto Cosio mentioned, “The firemen participate as first responders and provide basic life support or initial emergency aid to injured people. The molecular testing provided to the firemen not only helped prevent the spread of COVID-19 to their coworkers and families, but also the individuals they assist on a daily basis.”

The Peruvian Navy hosts NAMRU-6 at their flagship hospital in Lima, and naval clinics in Iquitos and Puerto Maldonado. NAMRU-6 conducts research on and surveillance of a wide range of infectious diseases of military and public health significance in the region; and anti-microbial resistance monitoring.

“As the host of NAMRU-6 for the past 37 years, the Peruvians have provided us with immeasurable support in advancing our infectious disease research mission,” said U.S. Navy Capt. William Howard, NAMRU-6 commanding officer. “When we received the request from the Bellavista Firefighters, we were more than happy to be able to help with the testing and continue our longstanding friendship.”

You also may be interested in...

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DoD Instruction 2000.30: Global Health Engagement Activities

Policy

This instruction establishes policy, assigns responsibilities, and prescribes procedures for the conduct of global health engagement activities with partner nation (PN) entities.

Japanese Encephalitis (JE) virus is a mosquito-borne flavivirus and the most common vaccine-preventable cause of encephalitis in Asia

Policy

Individuals deploying to areas in Pacific Command (PACOM) should be administered the JE vaccine in accordance with the latest PACOM Force Health Protection Guidance.

Guidance on Medications for Prophylaxis of Malaria 13-002

Policy

This document provides guidance and best practices for the chemoprophylaxis (use of medication to prevent malaria) of Service members serving in malaria endemic regions.

MHS Training Directive for Medical Stability Operations

Policy

MHS Training Directive for Medical Stability Operations

Joint Pub 3-07, Stability Operations, September 29, 2011

Policy

DoD Support to Foreign Disaster Relief Handbook

Policy

DoD Support to Foreign Disaster Relief Handbook

Showing results 1 - 14 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.